Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;39(1):1202-1212.
doi: 10.1080/02656736.2022.2121860.

Proactive esophageal cooling protects against thermal insults during high-power short-duration radiofrequency cardiac ablation

Affiliations

Proactive esophageal cooling protects against thermal insults during high-power short-duration radiofrequency cardiac ablation

Marcela Mercado Montoya et al. Int J Hyperthermia. 2022.

Abstract

Background: Proactive cooling with a novel cooling device has been shown to reduce endoscopically identified thermal injury during radiofrequency (RF) ablation for the treatment of atrial fibrillation using medium power settings. We aimed to evaluate the effects of proactive cooling during high-power short-duration (HPSD) ablation.

Methods: A computer model accounting for the left atrium (1.5 mm thickness) and esophagus including the active cooling device was created. We used the Arrhenius equation to estimate the esophageal thermal damage during 50 W/ 10 s and 90 W/ 4 s RF ablations.

Results: With proactive esophageal cooling in place, temperatures in the esophageal tissue were significantly reduced from control conditions without cooling, and the resulting percentage of damage to the esophageal wall was reduced around 50%, restricting damage to the epi-esophageal region and consequently sparing the remainder of the esophageal tissue, including the mucosal surface. Lesions in the atrial wall remained transmural despite cooling, and maximum width barely changed (<0.8 mm).

Conclusions: Proactive esophageal cooling significantly reduces temperatures and the resulting fraction of damage in the esophagus during HPSD ablation. These findings offer a mechanistic rationale explaining the high degree of safety encountered to date using proactive esophageal cooling, and further underscore the fact that temperature monitoring is inadequate to avoid thermal damage to the esophagus.

Keywords: Atrial fibrillation; atrioesophageal fistula; esophageal cooling; mathematical modeling; radiofrequency ablation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: MMM: employment with Insilico SE, consulting for Attune Medical; SRM: employment with Acutus Medical, consulting for Attune Medical; TGB: employment with Insilico SE; PHA: employment with Insilico SE; EK: equity and employment in Attune Medical. The rest of the authors declare no conflict of interest.

Figures

Figure 1
Figure 1
a) Physical situation to be modeled with an active cooling device located in the esophageal lumen. b) Model geometry including RF catheter, tissues near the ablation site and an active cooling device located in the esophageal lumen. The evaluation line (black line) for post-processing is shown across the ablated tissues, from tip of RF catheter to edge of active cooling device (with tissues including myocardium, fat and esophagus).
Figure 2
Figure 2
General view (a) and zoom-in (b) of the meshing around the electrode with 162,322 total elements and 102,250 around the catheter electrode. The color legend represents skewness element quality. Histograms of element quality around the electrode showing the skewness (c), volume versus length (d), and growth rate (e).
Figure 3
Figure 3
Progress of electrical variables (power, impedance, current and voltage) during RF pulse using 50W/10s (top) and 90W/4s (bottom). Note that power is almost constant during the RF pulse, with variations less than 2 W.
Figure 4
Figure 4
Temperature distributions during HPSD ablation using 50W/10s and 90W/4s, with (protection) and without (control) proactive esophageal cooling (scale in °C).
Figure 5
Figure 5
Temperature progress computed at different locations below the electrode during and after RF pulse for 50W/10s and 90W/4s, with (protection) and without (control) proactive esophageal cooling. Device wall and cooling water correspond to esophageal tissue in the control case in which no esophageal thermal cooling is used.
Figure 6
Figure 6
Lesion shapes (computed with fraction of damage θd = 63% after 90 s with the Arrhenius model) for 50W/10s and 90W/4s, with (protection) and without (control) proactive esophageal cooling.
Figure 7
Figure 7
Esophageal lesion transmurality (A) and maximum lesion width in the myocardial wall (B) computed with two fractions of damage θd (63% and 99%) just after the RF pulse and after 90 s, for 50W/10s and 90W/4s, and with (Protection) and without (Control) proactive esophageal cooling.

References

    1. Dagres N, Anastasiou-Nana M. Prevention of atrial-esophageal fistula after catheter ablation of atrial fibrillation. Curr Opin Cardiol. 2011. Jan;26(1):1–5. doi: 10.1097/HCO.0b013e328341387d. - DOI - PubMed
    1. Kapur S, Barbhaiya C, Deneke T, Michaud GF. Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation. Circulation. 2017. Sep 26;136(13):1247–1255. doi: 10.1161/CIRCULATIONAHA.117.025827. - DOI - PubMed
    1. Ha FJ, Han HC, Sanders P, Teh AW, O’Donnell D, Farouque O, Lim HS. Challenges and limitations in the diagnosis of atrioesophageal fistula. J Cardiovasc Electrophysiol. 2018. Jun;29(6):861–871. doi: 10.1111/jce.13494. - DOI - PubMed
    1. Della Rocca DG, Magnocavallo M, Natale VN, Gianni C, Mohanty S, Trivedi C, Lavalle C, Forleo GB, Tarantino N, Romero J, Zhang X, Bassiouny M, Al-Ahmad A, Burkhardt DJ, Gallinghouse JG, Sanchez JE, Horton RP, Di Biase L, Natale A. Clinical presentation, diagnosis, and treatment of atrioesophageal fistula resulting from atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2021. Sep;32(9):2441–2450. doi: 10.1111/jce.15168. - DOI - PubMed
    1. Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, Leong-Sit P, Novak P, Badra-Verdu M, Sapp J, Mangat I, Khoo C, Steinberg C, Bennett MT, Tang ASL, Khairy P; CIRCA-DOSE Study Investigators. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation. 2019. Nov 26;140(22):1779–1788. doi: 10.1161/CIRCULATIONAHA.119.042622. - DOI - PubMed

Publication types